•
Dec 31, 2012

Jazz Pharmaceuticals Q4 2012 Earnings Report

Total Revenue
$184M
Previous year: $83.5M
+119.9%
EPS
$1.53
Previous year: $0.89
+71.9%
Gross Profit
$158M
Previous year: $79.7M
+98.2%
Cash and Equivalents
$387M
Previous year: $82.1M
+371.8%
Total Assets
$1.97B
Previous year: $254M
+675.5%

Jazz Pharmaceuticals

Jazz Pharmaceuticals